ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 340

Increased Physical Activity in Gout Patients Correlates with Better Prognosis, Decreased Pain, and Suppressed C-Reactive Protein Levels

Naomi Schlesinger1, Kyle Jablonski 2, Peter Harb 3, Caitlin Henry 3, Emily Schwarz 3, Ifeoma Okafor 3, Wael Jarjour 4 and Nicholas Young 5, 1Rutgers Health- RWJ Medical School, New Brunswick, NJ, 2The Ohio State University Wexner Medical Center, Division of Immunology and Rheumatology, Columbus, 3Ohio State College of Medicine, Columbus, 4Ohio State College of Medicine, Columbus, OH, 5The Ohio State University Wexner Medical Center, Division of Immunology and Rheumatology, Columbus, OH

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: C-reactive protein (CRP), exercise, gout, inflammation and arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Metabolic & Crystal Arthropathies Poster I: Clinical

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Regular exercise programs were previously thought to be inappropriate in patients with rheumatic diseases because of the potential to exacerbate inflammation. However, while recent paradigm-shifting studies have demonstrated that moderate physical activity can suppress inflammatory burden in chronic disease states, the impact in patients with gout has not been studied extensively hitherto. Consequently, clinical practice guidelines for gout released by the ACR (2012) and the ACP (2017) do not even address exercise as an interventional strategy. In a mouse model of gout, we have recently demonstrated that regular low/moderate intensity exercise regimens can reduce localized MSU crystal-induced inflammation. Therefore, the objective of this study was to examine the correlation of physical activity levels with clinical data in gout patients.

Methods: During scheduled appointments, gout patients not experiencing a flare at the time of visit were recruited from our clinics and consented to participate in the study (N = 30). International physical activity questionnaires (IPAQ) were completed to access current levels of daily/weekly physical activity. Clinical data was collected during the patient visit, including BMI, age, years since diagnosis, flares per year, perceived pain at the time of visit and in the past 4 weeks, and C-reactive protein (CRP) levels. Results were analyzed with individual unpaired t-tests with Welch’s correction and one-way ANOVA without Gaussian distribution and multiple comparisons to analyze the mean rank of each data set with that of every other to obtain p-values. Statistical significance was determined to be p < 0.05.

Results: The IPAQ survey, which has been previously used in studies of rheumatologic diseases, separated the gout patients in this study into physically active (IPAQ > 1400; N = 16) and physically inactive cohorts (IPAQ < 1400; N = 14) (p < 0.001). Average age, BMI, or years since diagnosis did not significantly differ between cohorts. However, physically active gout patients had 7 fewer flares per year, which corresponded to a 12-fold reduction (p < 0.01). Furthermore, physical activity correlated with a 10-fold decrease in CRP levels by an average of 2 mg/L (p < 0.01). In addition, perceived pain at the time of visit and over the past 4-week period was down 4.6-fold (p < 0.01) and 2.8-fold (p < 0.05), respectively.

Conclusion: These epidemiological and clinical data suggest that increased physical activity is beneficial in patients with gout and should be explored further as a therapeutic intervention. Regular exercise may be efficacious during intervals between flares and could function as a flare prophylaxis. While rest and decreased movement will still be recommended to a patient experiencing a gout flare, further characterization of exercise therapy may lead to a standardized exercise regimen to be performed during times of clinical inactivity and serve as part of the treatment for flare prophylaxis.

Physically active gout patients have lower C-reactive protein levels, less flares per year, and decreased pain perception compared to those that are not physically active.


Disclosure: N. Schlesinger, amgen, 2, horizon pharma, 5, IFM Therapeutics, 5, Mallinckrodt Pharmaceuticals, 5, Novartis, 5, olatec, 5, pfizer, 2, Selecta Biosciences, 5; K. Jablonski, None; P. Harb, None; C. Henry, None; E. Schwarz, None; I. Okafor, None; W. Jarjour, None; N. Young, None.

To cite this abstract in AMA style:

Schlesinger N, Jablonski K, Harb P, Henry C, Schwarz E, Okafor I, Jarjour W, Young N. Increased Physical Activity in Gout Patients Correlates with Better Prognosis, Decreased Pain, and Suppressed C-Reactive Protein Levels [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/increased-physical-activity-in-gout-patients-correlates-with-better-prognosis-decreased-pain-and-suppressed-c-reactive-protein-levels/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-physical-activity-in-gout-patients-correlates-with-better-prognosis-decreased-pain-and-suppressed-c-reactive-protein-levels/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology